# Sumitomo Chemical India (SUMICHEM) — Stock analysis

> Faxioms all-in-one stock review. Canonical page: https://faxioms.com/stocks/sumichem

## Current market snapshot

- Exchange: NSE
- Country: India
- Price: ₹329.6
- Change: +0.53%
- As of: 2026-11-06
- 1D return: +0.53%
- 5D return: +4.60%
- 1M return: -19.88%
- Latest complete quarter: fy27_q2

## Faxioms Analysis

_As of 2026-11-06_

### Technical Outlook

SUMICHEM (₹329.60) remains in a strong daily downtrend, trading below all key moving averages and the Supertrend on daily, weekly, and monthly timeframes. The ADX of 53.44 confirms high trend conviction despite the stock being near multi-month lows (+7.2% above the 252-day low). A recent +4.5% move on November 4 was an anomaly within this broader decline, which has seen returns of -31.3% over one year and -37.8% since inception. Risk is elevated with annualized volatility at +35.1% and a current drawdown of -49.5%. Price action is consolidating near immediate support at ₹329.50, with resistance clustered between ₹333.85 and ₹339.85. An active monthly Inside Bar pattern suggests potential for a breakout or breakdown from this compressed range.

- Trend: Strong bearish momentum on daily charts (ADX 53.44); price below all MAs and Supertrend across daily, weekly, and monthly horizons.
- Levels: Immediate support at ₹329.50; nearest resistance at ₹333.85 (+1.29%) and ₹339.85 (+3.11%).
- Risk: High volatility (+35.1%) and significant drawdown (-49.5%); stock trades near 252-day lows.
- Setup: Active monthly Inside Bar formation indicates consolidation; confirmation requires a decisive move above ₹333.85 or breakdown below ₹329.50.

- Inside Bar
- Bearish Engulfing Reversal
- Outside Bar

### News Context

Sumitomo Chemical India reported unaudited financial results for the half-year ended September 30, 2026, on October 26, 2026. Standalone revenue from operations was ₹8,909.08 million for the quarter and ₹19,449.83 million for the half-year, with standalone profit after tax at ₹1,560.42 million and ₹3,725.71 million respectively. Consolidated figures showed revenue of ₹9,073.09 million (quarter) and ₹19,706.55 million (half-year), with consolidated profit after tax of ₹1,674.04 million and ₹3,719.18 million respectively. The company noted that H1 FY27 revenue declined 1% year-on-year to INR 1,971 crores in its earnings call transcript, while net profit rose 5% to INR 372 crores, impacted by high-cost inventory in Q2 which compressed margins.

Leadership transitioned on September 1, 2026, with Dr. Suresh Ramachandran assuming the role of Managing Director, succeeding Mr. Chetan Shah who became Chairman. The company announced a 'Good to Great' transformation initiative and provided updates on capex projects at Dahej (INR 150 crores) and Tarapur (INR 20 crores). An MOU signed by its parent entity for semiconductor chemicals was confirmed, though no concrete plans or roles for the Indian listed entity have been defined yet. Additionally, the company disclosed an exceptional item of ₹151.86 million related to new labour codes in Q2 and received a ₹268.96 million business-interruption insurance claim relating to the 2022–23 fire at the Bhavnagar plant.

Technically, the stock closed at ₹329.60 on November 6, 2026, with a market capitalization of approximately ₹16,364.49 crore. The daily trend is bearish, with the stock down 31.3% over the past year and 37.2% over three months. Resistance levels are identified at ₹333.85, ₹339.85, and ₹344.20, while support lies at ₹329.50, ₹323.50, and ₹319.15.

- H1 FY27 Financials: Standalone revenue was ₹19,449.83 million and PAT was ₹3,725.71 million; consolidated revenue was ₹19,706.55 million and PAT was ₹3,719.18 million. Earnings call transcript notes H1 revenue down 1% YoY but net profit up 5% YoY, impacted by high-cost inventory in Q2.
- Leadership & Strategy: Dr. Suresh Ramachandran became MD on September 1, 2026, succeeding Chairman Chetan Shah. A 'Good to Great' transformation initiative was announced alongside capex updates for Dahej (INR 150 crores) and Tarapur (INR 20 crores).
- Parent Entity Development: An MOU for semiconductor chemicals was signed by the parent entity, but the company clarified that no concrete plans or specific roles for the Indian listed entity have been defined yet.
- Technical Position: Stock closed at ₹329.60 on November 6, 2026, with a bearish daily trend. Year-to-date return is -29.8%, with resistance at ₹333.85 and support at ₹329.50.

- Sumitomo Chemical India Limited has informed the Exchange about Transcript |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
- Sumitomo Chemical India Limited has informed the Exchange about Link of Recording |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
- Sumitomo Chemical India Limited has submitted to the Exchange, the financial results for the quarter and half-year ended 30th September, 2026. |SUBJECT: Outcome of Board Meeting
- Integrated Filing (Financial) for the quarter and half-year ended 30th September, 2026. |SUBJECT: Integrated Filing- Financial
- Integrated Filing- Financials|Original|

### Official Filings

Sumitomo Chemical India Limited (SCIL) reported H1 FY27 results with revenue of ₹1,971 crore (down 1% YoY) and net profit of ₹372 crore (up 5% YoY). The Board approved standalone revenue of ₹8,909.08 million for Q2 and ₹19,449.83 million for H1, with PAT at ₹1,560.42 million and ₹3,725.71 million respectively. Profitability in Q2 was compressed by high-cost inventory absorption, though margins normalized by quarter-end. Domestic revenue grew 2% to ₹774 crore, while exports fell 23% to ₹127 crore due to a 13% rainfall deficit and delayed monsoon onset. SCIL maintains a cash position of approximately ₹2,523 crore and has approved ~₹150 crore CAPEX for a herbicide intermediate plant at Dahej. Leadership transitioned to Dr. Suresh Ramachandran as Managing MD on September 1, 2026.

- H1 FY27 Revenue: ₹1,971 crore (-1% YoY); Net Profit: ₹372 crore (+5% YoY).
- Q2 Standalone Results: Revenue ₹8,909.08 million; PAT ₹1,560.42 million.
- Export Decline: Exports fell 23% to ₹127 crore due to weather impacts; Domestic revenue grew 2% to ₹774 crore.
- Capex & Cash: Approved ₹150 crore CAPEX for Dahej plant; Cash balance ~₹2,523 crore.

- [Sumitomo Chemical India Limited has informed the Exchange about Transcript |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SUMICHEM_30102026172704_Letter_to_SEs_Transcript_of_Earnings_Call_Q2_26_27_signed.pdf)
- [Sumitomo Chemical India Limited has informed the Exchange about Link of Recording |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SUMICHEM_27102026172539_Letter_to_SEs_Audio_Recording_Earnings_Call_Q2_26_27_signed.pdf)
- [Sumitomo Chemical India Limited has submitted to the Exchange, the financial results for the quarter and half-year ended 30th September, 2026. |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/SUMICHEM_26102026155013_Outcome_of_Board_Meeting_Signed.pdf)
- [Integrated Filing (Financial) for the quarter and half-year ended 30th September, 2026. |SUBJECT: Integrated Filing- Financial](https://nsearchives.nseindia.com/corporate/SUMICHEM_26102026155607_Integrated_Filings_DSC.pdf)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1745819_26102026040430_WEB.xml)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1745820_26102026040446_WEB.xml)
- [Sumitomo Chemical India Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation](https://nsearchives.nseindia.com/corporate/SUMICHEM_26102026231442_26_10_2026_Letter_to_SEs_Investor_Presentation_Q2_2026_27_signed.pdf)
- [Sumitomo Chemical India Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SUMICHEM_19102026140803_Letter_to_SEs_Earnings_Call_Q2_26_27_signed.pdf)
- [Sumitomo Chemical India Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SUMICHEM_19102026143201_Letter_to_SEs_Earnings_Call_Q2_26_27_.pdf)
- [Financial Results |Meeting Date: 26-Oct-2026](https://nsearchives.nseindia.com/corporate/SUMICHEM_06102026092619_BM_Intimation_26_10_2026.pdf)

### Fundamentals

Sumitomo Chemical India’s operating trajectory shows a near-term deceleration despite robust historical profitability. In Q2 FY2026-27, revenue from operations fell to ₹907 crore from ₹1,063 crore in Q1, with net profit declining sequentially to ₹157 crore (EPS: ₹3.14) from ₹215 crore (EPS: ₹4.3). This quarterly softness contrasts with the TTM trend, where sales grew to ₹3,168 crore and net profit rose to ₹558 crore, supported by a 3-year ROE of 17% and ROCE of 23%. Earnings quality remains strong, evidenced by CFO/EBITDA conversion of 91% in Mar 2026, though the cash conversion cycle extended to 161 days due to rising inventory days (166). The balance sheet is stable; borrowings decreased to ₹46 crore as of Sep 2026, while investments grew to ₹1,433 crore. Promoter holding remains steady at 75%, with DIIs increasing their stake to 9.68%.

- Q2 FY2026-27 revenue declined to ₹907 crore (from ₹1,063 crore in Q1), driving sequential drops in net profit (₹157 crore) and EPS (₹3.14).
- TTM performance remains positive with sales at ₹3,168 crore and net profit at ₹558 crore, maintaining a 3-year ROE of 17%.
- Earnings quality is high (CFO/EBITDA: 91%), but working capital efficiency weakened, with the cash conversion cycle rising to 161 days and inventory days reaching 166.
- Borrowings reduced to ₹46 crore as of Sep 2026, while total assets expanded to ₹4,979 crore; promoter holding is unchanged at 75%.

### Bear Case

Technical indicators for Sumitomo Chemical India reflect a pronounced bearish environment as of November 6, 2026. The stock is trading at ₹329.60, well below its recent high of ₹330.75, with daily and weekly Supertrend signals both indicating a bearish direction. Momentum is weak, evidenced by the Minus DI (35.21) significantly outweighing the Plus DI (9.03) on a daily basis, and an ADX of 53.44 suggesting strong downward trend intensity. Performance metrics show substantial erosion: the stock has fallen 37.2% over three months, 33.5% over six months, and 31.3% over the past year. Year-to-date returns stand at -29.8%, while the current drawdown is -49.5%, approaching the maximum historical drawdown of -51.9%. Volatility remains elevated at 35.1% annualized. Immediate support lies near ₹329.50, but downside risks persist toward ₹323.50 and ₹319.15 if selling pressure continues.

- Strong bearish momentum: Daily ADX is 53.44 with Minus DI (35.21) far exceeding Plus DI (9.03); Supertrend is bearish on daily, weekly, and monthly timeframes.
- Significant underperformance: Returns are -37.2% (3m), -33.5% (6m), -31.3% (1y), and -29.8% YTD; current drawdown is -49.5% vs max drawdown of -51.9%.
- High volatility and liquidity: Annualized volatility is +35.1% with ATR at 4.51%; daily turnover was ₹6.29 crore with 7069 trades.
- Key price levels: Current price ₹329.60 faces immediate support at ₹329.50 (pivot) and ₹323.50 (low); resistance exists at ₹333.85.

- [Sumitomo Chemical India Limited has informed the Exchange about Transcript |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SUMICHEM_30102026172704_Letter_to_SEs_Transcript_of_Earnings_Call_Q2_26_27_signed.pdf)
- [Sumitomo Chemical India Limited has informed the Exchange about Link of Recording |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SUMICHEM_27102026172539_Letter_to_SEs_Audio_Recording_Earnings_Call_Q2_26_27_signed.pdf)
- [Sumitomo Chemical India Limited has submitted to the Exchange, the financial results for the quarter and half-year ended 30th September, 2026. |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/SUMICHEM_26102026155013_Outcome_of_Board_Meeting_Signed.pdf)
- [Integrated Filing (Financial) for the quarter and half-year ended 30th September, 2026. |SUBJECT: Integrated Filing- Financial](https://nsearchives.nseindia.com/corporate/SUMICHEM_26102026155607_Integrated_Filings_DSC.pdf)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1745819_26102026040430_WEB.xml)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1745820_26102026040446_WEB.xml)
- [Sumitomo Chemical India Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation](https://nsearchives.nseindia.com/corporate/SUMICHEM_26102026231442_26_10_2026_Letter_to_SEs_Investor_Presentation_Q2_2026_27_signed.pdf)
- [Sumitomo Chemical India Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SUMICHEM_19102026140803_Letter_to_SEs_Earnings_Call_Q2_26_27_signed.pdf)
- [Sumitomo Chemical India Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SUMICHEM_19102026143201_Letter_to_SEs_Earnings_Call_Q2_26_27_.pdf)
- [Financial Results |Meeting Date: 26-Oct-2026](https://nsearchives.nseindia.com/corporate/SUMICHEM_06102026092619_BM_Intimation_26_10_2026.pdf)

### FAQs

**What were Sumitomo Chemical India's financial results for H1 FY27, and how did management explain the performance?**

For the half-year ended September 30, 2026, consolidated revenue was ₹19,706.55 million (down 1% YoY) with a net profit of ₹3,719.18 million (up 5% YoY). Management attributed margin compression in Q2 to high-cost inventory. The company also noted an exceptional item of ₹151.86 million related to new labour codes in Q1.

**Has the company made concrete progress on its semiconductor chemicals strategy?**

While the parent entity signed an MOU for semiconductor chemicals, the company confirmed that no concrete plans or specific roles for the Indian listed entity have been defined yet. Additionally, the 'Good to Great' transformation initiative is underway, with capex projects at Dahej (₹150 crores) and Tarapur (₹20 crores) currently in progress.

**How has the stock performed technically over the past year, and what are the key price levels?**

The stock has declined 31.3% over the last year and is currently trading near ₹329.60. Technical indicators show a bearish trend across daily, weekly, and monthly timeframes. Immediate support is seen at ₹329.50, while resistance levels are located at ₹333.85 and ₹339.85.

**Are there any significant changes in leadership or one-off financial items affecting recent results?**

Dr. Suresh Ramachandran assumed the role of Managing Director on September 1, 2026, succeeding Mr. Chetan Shah, who became Chairman. Financially, the quarter ended June 30, 2026, included a ₹268.96 million business-interruption insurance claim received from the 2022–23 Bhavnagar plant fire, classified as an exceptional item.

- [Sumitomo Chemical India Limited has informed the Exchange about Transcript |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SUMICHEM_30102026172704_Letter_to_SEs_Transcript_of_Earnings_Call_Q2_26_27_signed.pdf)
- [Sumitomo Chemical India Limited has informed the Exchange about Link of Recording |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SUMICHEM_27102026172539_Letter_to_SEs_Audio_Recording_Earnings_Call_Q2_26_27_signed.pdf)
- [Sumitomo Chemical India Limited has submitted to the Exchange, the financial results for the quarter and half-year ended 30th September, 2026. |SUBJECT: Outcome of Board Meeting](https://nsearchives.nseindia.com/corporate/SUMICHEM_26102026155013_Outcome_of_Board_Meeting_Signed.pdf)
- [Integrated Filing (Financial) for the quarter and half-year ended 30th September, 2026. |SUBJECT: Integrated Filing- Financial](https://nsearchives.nseindia.com/corporate/SUMICHEM_26102026155607_Integrated_Filings_DSC.pdf)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1745819_26102026040430_WEB.xml)
- [Integrated Filing- Financials|Original|](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1745820_26102026040446_WEB.xml)
- [Sumitomo Chemical India Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation](https://nsearchives.nseindia.com/corporate/SUMICHEM_26102026231442_26_10_2026_Letter_to_SEs_Investor_Presentation_Q2_2026_27_signed.pdf)
- [Sumitomo Chemical India Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SUMICHEM_19102026140803_Letter_to_SEs_Earnings_Call_Q2_26_27_signed.pdf)
- [Sumitomo Chemical India Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates](https://nsearchives.nseindia.com/corporate/SUMICHEM_19102026143201_Letter_to_SEs_Earnings_Call_Q2_26_27_.pdf)
- [Financial Results |Meeting Date: 26-Oct-2026](https://nsearchives.nseindia.com/corporate/SUMICHEM_06102026092619_BM_Intimation_26_10_2026.pdf)
## Technical analytics

- As of: 2026-11-06
- Daily trend: Strong Downtrend
- Weekly trend: Weak Downtrend
- Pivot point: ₹329.5
- Risk regime: Higher Price Risk

### Support levels
- 310.85
- 323.5
- 319.15

### Resistance levels
- 413.5625
- 453.8
- 500.5794921875

### Return and range metrics

| Metric | Value |
| --- | --- |
| return_1 | +0.53% |
| return_10 | -8.60% |
| return_1m | -21.16% |
| return_1y | -31.34% |
| return_20 | -19.88% |
| return_3m | -37.24% |
| return_5 | +4.60% |
| return_6m | -33.46% |
| return_since_start | -37.79% |
| return_ytd | -29.80% |

### Risk and volatility metrics

| Metric | Value |
| --- | --- |
| state | high_risk |
| label | Higher price risk |
| summary | Recent drawdown or price variability is materially high and may lead to larger short-term outcomes. |
| maximum_drawdown | -51.87% |
| annualized_volatility | +35.14% |

## Quarterly financials

- Latest complete quarter: fy27_q2

# Sumitomo Chemical India Limited FY2026-27 Q2: Revenue and profit decline sequentially and year on year

Consolidated revenue from operations fell 14.7% quarter on quarter to ₹907 crore and was 2.4% lower year on year. Profit for the period declined 26.6% sequentially to ₹157 crore and was 11.5% below the year-earlier quarter; basic EPS was ₹3.14, down from ₹4.30 in Q1 FY2026-27 and ₹3.56 in Q2 FY2025-26.

## Revenue eases from Q1

Revenue from operations was ₹907 crore, compared with ₹1,063 crore in Q1 FY2026-27 and ₹930 crore in Q2 FY2025-26. It had been ₹568 crore in Q3 FY2025-26 and ₹684 crore in Q4 FY2025-26. Total income was ₹951 crore, down 14.4% from ₹1,111 crore in Q1 and 1.8% from ₹969 crore a year earlier. Other income was ₹43.6 crore in Q2.

## Expenses and earnings

Total expenses declined 12.8% quarter on quarter to ₹741 crore, less than the 14.7% fall in revenue. Expenses were 1.4% higher than in Q2 FY2025-26. Cost of materials consumed was ₹439 crore, purchases of stock in trade ₹59.4 crore, changes in inventories ₹39.9 crore and employee benefit expense ₹70.2 crore. Other expenses rose 2.7% sequentially to ₹113 crore, while finance costs were ₹1.9 crore, down from ₹2.0 crore in Q1.

Profit before tax was ₹210 crore, down 27.1% from Q1 and 11.6% year on year. Profit before exceptional items and tax was also ₹210 crore, compared with ₹261 crore in Q1. Tax expense declined 28.4% sequentially to ₹52.8 crore. Profit for the period was ₹157 crore; ₹157.2 crore was attributable to owners of the parent and ₹16.8 lakh to non-controlling interests.

## Balance sheet and working capital

At 30 September 2026, cash and cash equivalents were ₹52.1 crore, compared with ₹68.9 crore at 31 March 2026. Non-current investments increased to ₹486.7 crore from ₹265.5 crore, while non-current loans rose to ₹400.7 crore from ₹150.4 crore over the same dates.

Inventories stood at ₹747 crore, down from ₹766 crore at 31 March. Trade receivables increased to ₹887 crore from ₹736 crore, and trade payables rose to ₹451 crore from ₹397 crore. Current liabilities were ₹1,189 crore, compared with ₹970 crore at the prior financial year-end.

## Key Takeaway

Q2 brought sequential and year-on-year declines in revenue and profit, with expenses falling less than revenue quarter on quarter. The balance sheet also showed lower cash and higher non-current investments and loans, alongside increased receivables and current liabilities.

### Ratios

## Shareholding pattern

- Quarter: FY2027-Q1
- As of: 2026-06-30
- Promoter holding: +75.00%
- FII holding: +3.02%
- DII holding: +9.33%
- Mutual fund holding: +7.27%
- Retail holding: +6.28%
- Promoter pledged: +0.00%

### Major reported shareholders

- Sumitomo  Chemical Co. Ltd. — +75.00% (Bodies Corporate)
- Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Flexi Cap Fund — +2.28%
- Edelweiss Trusteeship Co Ltd Ac- Edelweiss Mf Ac- Edelweiss Mid Cap Fund — +1.24%
- Hsbc Mutual Fund - Hsbc Small Cap Fund — +1.09%

## Official filings

- 2026-10-30 — Generic Announcement: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_30102026172704_Letter_to_SEs_Transcript_of_Earnings_Call_Q2_26_27_signed.pdf)
- 2026-10-27 — Generic Announcement: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_27102026172539_Letter_to_SEs_Audio_Recording_Earnings_Call_Q2_26_27_signed.pdf)
- 2026-10-26 — Generic Announcement: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_26102026155013_Outcome_of_Board_Meeting_Signed.pdf)
- 2026-10-26 — Generic Announcement: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_26102026155607_Integrated_Filings_DSC.pdf)
- 2026-10-26 — Financial Results Filing: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1745819_26102026040430_WEB.xml)
- 2026-10-26 — Financial Results Filing: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/INTEGRATED_FILING_INDAS_1745820_26102026040446_WEB.xml)
- 2026-10-26 — Earnings Presentation: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_26102026231442_26_10_2026_Letter_to_SEs_Investor_Presentation_Q2_2026_27_signed.pdf)
- 2026-10-19 — Generic Announcement: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_19102026140803_Letter_to_SEs_Earnings_Call_Q2_26_27_signed.pdf)
- 2026-10-19 — Generic Announcement: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_19102026143201_Letter_to_SEs_Earnings_Call_Q2_26_27_.pdf)
- 2026-10-06 — Board Meeting Notice: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_06102026092619_BM_Intimation_26_10_2026.pdf)
- 2026-10-06 — Generic Announcement: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_06102026112915_Letter_Reg_74_5.pdf)
- 2026-10-01 — Generic Announcement: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_17682_WebXMLFile_20261001_170527768.xml)
- 2026-10-01 — Board Meeting Notice: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_17682_WebXMLFile_20261001_170527768.xml)
- 2026-08-25 — Generic Announcement: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_25082026110033_Analyst_Meet_03_09_2026.pdf)
- 2026-08-10 — Generic Announcement: Sumitomo Chemical India Limited — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_10082026110510_AnalystMeet_19_08_2026.pdf)
- 2026-07-28 — Generic Announcement: Sumitomo Chemical India Ltd. held its Annual General Meeting on July 27, 2026, where resolutions were passed including the adoption of financial statements for the year ended March 31, 2026, and a dividend declaration of ₹1.30 per share. Key appointments and reappointments were approved: Dr. Suresh Ramachandran was re-appointed and promoted to Managing Director effective September 1, 2026; Mr. N. Sivaraman was reappointed as an Independent Director from September 1, 2026, for three years; and Mr. Anand Mohan Tiwari was appointed as an Independent Director from August 31, 2026, for two years. Mr. Chetan Shah transitioned from Managing Director to Non-Executive Non-Independent Director from September 1, 2026, with approved fees for one year. Approval was also given for material related party transactions with Sumitomo Chemical Company, Limited for FY 2026-27 and ratification of cost auditor remuneration. — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_28072026174150_Letter_to_SEs_with_Scrutinizer_Report_and_Excel_sheets_26th_AGM_signed.pdf)
- 2026-07-27 — Earnings Presentation: Sumitomo Chemical India Limited has released its investor presentation for the quarter ended June 30, 2026. The company reported a 1% year-over-year revenue increase to Rs. 1,063 crore, with exports growing by 26%. Gross profit rose 4% to Rs. 985.5 crore, and EBITDA increased 6% to Rs. 233 crore. Net profit reached Rs. 215 crore, boosted by a Rs. 26.9 crore insurance claim related to a prior year fire incident. The company also announced board member changes effective September 1, 2026, including the appointment of Dr. Suresh Ramachandran as Managing Director. — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_27072026201434_Letter_to_SEs_Investor_Presentation_Q1_2026_27_combined_signed.pdf)
- 2026-07-27 — Generic Announcement: Mr. Ninad D. Gupte has resigned as a Non-Executive, Non-Independent Director of Sumitomo Chemical India Ltd. effective August 31, 2026, for personal reasons. He also holds directorships at Excel Industries Limited, where he chairs the Nomination & Remuneration Committee and is a member of the Audit and Risk Management Committees. — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_27072026133604_Signed_NDG_Resignation.pdf)
- 2026-07-27 — Generic Announcement: The 26th Annual General Meeting of Sumitomo Chemical India Limited was held on July 27, 2026, via video conferencing. Key agenda items included the adoption of audited financial statements for the year ended March 31, 2026, declaration of a dividend of ₹1.30 per equity share, and re-appointment of Dr. Suresh Ramachandran. Special business involved the re-appointment of Mr. N. Sivaraman and Mr. Anand Mohan Tiwari as Independent Directors, and the appointment of Mr. Chetan Shah as a Non-Executive Non-Independent Director. Dr. Suresh Ramachandran was promoted to Managing Director effective September 1, 2026. The meeting also addressed advisory fees for Mr. Chetan Shah, material related party transactions with Sumitomo Chemical Company, Limited, and ratification of remuneration for Cost Auditors. — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_27072026164742_AGM_Proceedings_2025_26_signed.pdf)
- 2026-07-27 — Generic Announcement: Sumitomo Chemical India Ltd. reported its unaudited financial results for the quarter ended June 30, 2026, on July 27, 2026. The company's standalone revenue from operations was ₹10,540.75 million, with a profit after tax of ₹2,165.29 million. Consolidated revenue from operations was ₹10,633.46 million, with a profit after tax of ₹2,145.14 million. The company also disclosed receiving an insurance claim of ₹268.96 million for business interruption due to a fire incident at its Bhavnagar plant. — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_27072026133818_Final_Integrated_Filings_DSC.pdf)
- 2026-07-27 — Generic Announcement: Sumitomo Chemical India Ltd. announced its unaudited financial results for the quarter ended June 30, 2026, on July 27, 2026. The company reported revenue from operations of ₹10,540.75 million for the standalone quarter and ₹10,633.46 million for the consolidated quarter. The Board of Directors approved these results, which were reviewed by the Audit Committee. The company also noted an insurance claim of ₹268.96 million received for business interruption due to a fire incident at the Bhavnagar plant. — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_27072026132520_Outcome_of_BM_DSC.pdf)
- 2026-07-14 — Generic Announcement: Sumitomo Chemical India Limited, through its R&T Agent MUFG Intime India Private Limited, has provided a compliance certificate for the quarter ended June 30, 2026. This confirms that securities received for dematerialization were processed, listed on stock exchanges, and that certificates were mutilated and cancelled with depository names substituted in the register of members within the prescribed timelines, as per Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_14072026172629_Letter_Reg_74_5_signed.pdf)
- 2026-07-03 — Generic Announcement: Sumitomo Chemical India Limited will hold its 26th Annual General Meeting on July 27, 2026, via video conference. Key agenda items include adopting the financial statements for the year ended March 31, 2026, declaring a dividend, and appointing/reappointing directors. Specifically, Dr. Suresh Ramachandran is proposed for promotion to Managing Director, Mr. N Sivaraman for reappointment as Independent Director for a second term (September 1, 2026 - August 31, 2029), Mr. Anand Mohan Tiwari for appointment as Independent Director (August 31, 2026 - August 30, 2028), and Mr. Chetan Shah as Non-Executive Non-Independent Director. The meeting will also seek approval for advisory and sitting fees for Mr. Chetan Shah, not exceeding ₹30 million for the period September 1, 2026, to August 31, 2027, and for material related party transactions with Sumitomo Chemical Company, Limited, Japan, aggregating up to ₹16,235 million for FY 2026-27. — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_03072026104513_Final_Revised_Notice.pdf)
- 2026-07-02 — Generic Announcement: Sumitomo Chemical India Limited will hold its 26th Annual General Meeting on July 27, 2026, via video conference. Key agenda items include adopting the financial statements for the year ended March 31, 2026, declaring a dividend, and appointing/reappointing directors. Specifically, Dr. Suresh Ramachandran is proposed for promotion to Managing Director, Mr. N Sivaraman for reappointment as Independent Director for a second term (September 1, 2026 - August 31, 2029), Mr. Anand Mohan Tiwari for appointment as Independent Director (August 31, 2026 - August 30, 2028), and Mr. Chetan Shah as Non-Executive Non-Independent Director. The meeting will also seek approval for advisory and sitting fees for Mr. Chetan Shah, not exceeding ₹30 million for the period September 1, 2026, to August 31, 2027, and for material related party transactions with Sumitomo Chemical Company, Limited, Japan, aggregating up to ₹16,235 million for FY 2026-27. — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_02072026155450_Notice_of_26th_AGM_FINAL.pdf)
- 2026-06-30 — Generic Announcement: Sumitomo Chemical India Limited will hold its 26th Annual General Meeting on July 27, 2026, via video conference. Key agenda items include adopting the financial statements for the year ended March 31, 2026, declaring a dividend, and appointing/reappointing directors. Specifically, Dr. Suresh Ramachandran is proposed for promotion to Managing Director, Mr. N Sivaraman for reappointment as Independent Director for a second term (September 1, 2026 - August 31, 2029), Mr. Anand Mohan Tiwari for appointment as Independent Director (August 31, 2026 - August 30, 2028), and Mr. Chetan Shah as Non-Executive Non-Independent Director. The meeting will also seek approval for advisory and sitting fees for Mr. Chetan Shah, not exceeding ₹30 million for the period September 1, 2026, to August 31, 2027, and for material related party transactions with Sumitomo Chemical Company, Limited, Japan, aggregating up to ₹16,235 million for FY 2026-27. — [Official attachment](https://nsearchives.nseindia.com/corporate/SUMICHEM_30062026112824_Notice_of_26th_AGM_FINAL.pdf)

## News and market events

- 2026-11-06 — Economic Times: **Quant Small Cap Fund adds Jio Platforms and 4 others; increases stake in Adani Power, 5 more** — Quant Small Cap Fund added Jio Platforms, Primo Chemicals, and three other stocks to its portfolio in October while increasing exposure to Adani Power and LIC Housing Finance. The fund exited five holdings including Delhivery and Jubilant Pharmova, reduced positions in Bandhan Bank and others, and maintained holdings in nearly 90 stocks. Managed by a team of seven investment professionals, the fund reported an AUM of Rs 30,809.27 crore in October, down from Rs 35,572 crore in September. — [Source](https://economictimes.indiatimes.com/mf/analysis/quant-small-cap-fund-adds-jio-platforms-and-4-others-increases-stake-in-adani-power-5-more/articleshow/135603855.cms)
- 2026-10-26 — CNBC-TV18: **Sumitomo Chemical Q2 Results: Net profit falls 12% as revenue and EBITDA decline** — Sumitomo Chemical India reported a 12.4% YoY decline in Q2 net profit to ₹156 crore, while revenue fell 2.5% to ₹891 crore. EBITDA declined 15.7% to ₹183 crore, and the EBITDA margin narrowed to 20.56% from 24% a year earlier. — [Source](https://www.cnbctv18.com/market/stocks/sumitomo-chemical-india-share-price-q2-results-net-profit-falls-12-as-revenue-and-ebitda-decline-20019687.htm)
- 2026-10-26 — CNBC-TV18: **Stocks to Watch for October 27: Tata Consumer, REC, DCM Shriram, Dalmia Bharat, defence stocks and more** — Stocks to Watch: Tata Consumer Products, REC, Dalmia Bharat, DCM Shriram, Sona BLW, Aavas Financiers, Aequs, Five-Star Business Finance and Genus Power are among the stocks in focus ahead of Tuesday’s trading session after Q2 results and key corporate announcements. — [Source](https://www.cnbctv18.com/photos/market/stocks-to-watch-for-october-27-tata-consumer-rec-dcm-shriram-dalmia-bharat-defence-share-price-20019656.htm)
- 2026-09-19 — BUSINESSTODAY: **Japan’s semiconductor push in India: Why Japanese companies are betting on materials, equipment and technology** — Japan’s semiconductor push in India: Why Japanese companies are betting on materials, equipment and technology — [Source](https://www.businesstoday.in/technology/news/story/japans-semiconductor-push-in-india-why-japanese-companies-are-betting-on-materials-equipment-and-technology-556636-2026-09-19)
- 2026-09-19 — The Hindu: **SEMICON India Day 2 sees 25 partnerships across chip manufacturing, supply chains, packaging and skills** — SEMICON India Day 2 highlights 25 partnerships aimed at enhancing India's semiconductor manufacturing and supply chain capabilities. — [Source](https://www.thehindubusinessline.com/news/semicon-india-day-2-sees-25-partnerships-across-chip-manufacturing-supply-chains-packaging-and-skills/article71483916.ece)
- 2026-09-18 — NEWS.WEBINDIA123.COM: **SEMICON India Day 2 sees 25 partnerships across chip manufacturing, supply chains, packaging and skills** — The second day of SEMICON India 2026 saw 25 announcements and collaborations across semiconductor manufacturing, materials, logistics, chip design, advanced packaging, power electronics and workforce development, as Indian and global companies expanded partnerships across the semiconductor value chain. — [Source](https://news.webindia123.com/news/articles/business/20260918/4500455.html)
- 2026-09-18 — Orissa POST: **SEMICON India 2026: 25 announcements, collaborations unveiled Day 2 - OrissaPOST** — New Delhi: Day 2 of SEMICON India 2026 witnessed 25 key announcements and collaborations covering various segments of the semiconductor value chain, including semiconductor manufacturing, materials, logistics, chip design, advanced packaging, power electronics and workforce development, according to a statement issued by the Ministry of Electronics and IT Friday. India’s Tata Electronics and L&T Semiconductor […] — [Source](https://www.orissapost.com/semicon-india-2026-25-announcements-collaborations-unveiled-day-2)
- 2026-09-18 — BUSINESSTODAY: **Tata Electronics partners with Japanese, Malaysian firms to boost semiconductor manufacturing in India** — Tata Electronics, Tata Electronics semiconductor, Tata Electronics semiconductor partnerships, Tata Electronics Dholera fab, Dholera semiconductor fab, Tata Electronics Gujarat, Tata Electronics Assam, Tata Electronics Jagiroad, semiconductor manufacturing India, semiconductor ecosystem India, India semiconductor industry, Tata semiconductor plant — [Source](https://www.businesstoday.in/latest/corporate/story/tata-electronics-partners-with-japanese-malaysian-firms-to-boost-semiconductor-manufacturing-in-india-556556-2026-09-18)
- 2026-08-19 — Mint: **Stock recommendations for 19 August from MarketSmith India** — MarketSmith India reveals its top stock recommendations for today, 19 August. Get expert insights into the best-performing stocks to guide your investment decisions. — [Source](https://www.livemint.com/market/stock-market-news/stock-recommendations-19-august-marketsmith-india-11787060744705.html)
- 2026-08-17 — Mint: **Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 17 August 2026** — Breakout stocks to buy or sell: Sumeet Bagadia recommends five breakout stocks to buy today — SJS Enterprises, Honasa Consumer, Suven Life Sciences, Sumitomo Chemical India, and Asahi India Glass. — [Source](https://www.livemint.com/market/stock-market-news/breakout-stocks-to-buy-or-sell-sumeet-bagadia-recommends-five-shares-to-buy-today-17-august-2026-11786927363028.html)
- 2026-08-17 — Mint: **Raja Venkatraman recommends three stocks for 17 August** — Market expert Raja Venkatraman shares his top stock picks for 17 August. Here’s his technical outlook and trade strategy. — [Source](https://www.livemint.com/market/stock-market-news/raja-venkatraman-recommends-three-stocks-for-17-august-11786781734398.html)
- 2026-07-27 — FREEPRESSJOURNAL.IN: **Sumitomo Chemical India Q1 Profit Rises 20% YoY To ₹216.5 Crore; Revenue At ₹1,054 Crore** — Sumitomo Chemical India Q1 FY27 standalone net profit rose 20.4 percent YoY to Rs 216.5 crore, while revenue from operations increased marginally to Rs 1,054 crore, aided by an insurance claim. — [Source](https://www.freepressjournal.in/business/sumitomo-chemical-india-q1-profit-rises-20-yoy-to-2165-crore-revenue-at-1054-crore)

## Business profile

**Strategic vision:** Manufactures and markets crop protection, environmental health, and animal nutrition products.

### Business segments
- **Crop Solutions:** This segment includes a range of chemical and organic products for crop protection and plant growth regulators.
- **Animal Nutrition:** The company provides products that address the dietary needs of animals.
- **Household, Public Health & Pest Control:** This category encompasses products for environmental health, professional pest control, household pesticides, fumigants, and rodenticides.

### Competitive strengths
- Integrated product portfolio sourced from parent company and subsidiaries.
- Established distribution network for domestic and international markets.
- Focus on research and development for chemical and biological solutions.

## Related stocks

- [Aarti Industries Limited (Chemicals)](https://faxioms.com/stocks/aartiind) — -0.47%
- [Atul Limited (Chemicals)](https://faxioms.com/stocks/atul) — -1.28%
- [Chambal Fertilizers & Chemicals Limited (Chemicals)](https://faxioms.com/stocks/chamblfert) — -0.90%
- [Deepak Fertilizers and Petrochemicals Corporation Limited (Chemicals)](https://faxioms.com/stocks/deepakfert) — -0.70%
- [Deepak Nitrite Limited (Chemicals)](https://faxioms.com/stocks/deepakntr) — -0.58%

## Freshness and sources

- Data as of: 2026-11-06
- Source: Faxioms public stock analysis API

Canonical: https://faxioms.com/stocks/sumichem
Markdown representation: https://faxioms.com/stocks/sumichem?render=md